June 30, 2020 / 11:35 AM / 8 days ago

BRIEF-Marinus Pharmaceuticals Provides Pipeline Update

June 30 (Reuters) - Marinus Pharmaceuticals Inc:

* MARINUS PHARMACEUTICALS - STATUS EPILEPTICUS PIVOTAL PHASE 3 TRIAL ON-TRACK TO BEGIN IN Q3 2020

* MARINUS PHARMACEUTICALS - ENROLLMENT IN PCDH19 PROOF-OF-CONCEPT TRIAL INCREASES TO 25-30 PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below